QTE
- Product code
- QTE
- Device name
- Thymidine Kinase Activity
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.6010
- Medical specialty
- Immunology
- Marketing pathway
- 510(K)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
In vitro test to measure thymidine kinase activity (TKa) to aid in monitoring disease progression of breast cancer patients.
Official FDA classification page: QTE
Classification and pathway per current FDA publications. Data from openFDA (CC0).